Rare diseases
Investigational molecules
Locations
Back to Poland1 804 clinical trials in Warsaw, Poland across 33 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)A study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis
PolandA study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.
PolandA study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome
PolandA study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy
PolandA study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn's disease
PolandA study of acalabrutinib and venetoclax for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have relapsed after initial treatment
PolandA study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
PolandA study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer
PolandA study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis
PolandA study comparing mifamurtide to sorafenib for treating high-risk osteosarcoma in children and young adults
PolandA study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis
PolandA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) prevention in older adults. Studies include evaluation of novel vaccine formulations and immune responses in various age groups.
Particular emphasis on vaccine development for adults aged 60 and older.
Comprehensive research on meningococcal vaccines across different age groups, from infants to toddlers. Studies evaluate safety profiles and immune responses to various vaccine formulations.
Focus on preventive healthcare through advanced vaccination strategies.
Studies investigating treatments for psoriasis and psoriatic arthritis, including novel biological therapies and their mechanisms of action.
Emphasis on moderate to severe cases requiring advanced therapeutic interventions.
Clinical research focusing on bladder cancer and innovative combination therapies. Studies evaluate treatment efficacy in early-stage non-muscle invasive cases.
Integration of targeted therapies with standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
